CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0676
(Tag F0676)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review the facility failed to ensure one of eight sampled residents (Resident 83) was provided a s...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review the facility failed to ensure one of eight sampled residents (Resident 83) was provided a shower three times a week in accordance with the facility practice and the scheduled number of showers for Resident 83. This failure had the potential to result in a negative impact to the resident's quality of life and self-esteem.
Findings:
During a review of Resident 83's admission Record, (document providing admission date, name, date of birth , emergency contact, insurance information, and diagnoses), dated 2/16/23, the face sheet indicated Resident 83 was admitted on [DATE] for a short term stay with Resident 83's daughter as the first emergency contact. Resident 83 had the following diagnosis on admit: intracranial injury (a condition where a sudden, external, physical blow damages the brain), traumatic subdural Hemorrhage (a condition of bleeding inside the skull, and pressure in the brain), Type 2 Diabetes (an impairment in the way the body regulates and uses sugar), chronic kidney disease (kidneys are damaged and cannot filter blood normally), congestive heart failure (a condition where the heart muscle doesn't pump blood normally), abnormal gait and mobility, hyperlipidemia (condition where fat molecules build up in the blood), syncope (fainting) and collapse (fall), history of falling, chronic pain.
During a review of Resident 83's document titled MDS 3.0 (Minimum Data Set (MDS) is a standardized assessment tool that measures health status in nursing home residents.), dated 12/21/22, indicated in Section C Cognitive Patterns a Brief Interview for Mental Status (BIMS- test is used to get a quick snapshot of how well a resident is functioning cognitively at the moment. A score of 13 to 15 suggests the patient is cognitively intact, 8 to 12 suggests moderately impaired and 0 to 7 suggests severe impairment.) was completed and indicated Resident 83 had a BIMS of 3 suggesting his cognitive status was severely impaired. MDS 3.0 section G Functional Status for Bathing How resident takes full-body bath/shower, sponge bath, and transfers in /out of tub/shower .4. Total dependence .
During an interview on 2/15/23, at 11:02 a.m., with Resident 83's Daughter who is his Responsible Party/Emergency contact (RP), the RP stated her father was upset that he did not have a shower for two weeks.
During a concurrent interview and record review on 2/15/23, at 1:36 p.m. with the Licensed Vocational Nurse (LVN) 1, Resident 83's ADL (Activities of Daily Living- shower/bath, teeth brushed and more) Bathing/Shower documentation for January 2023, dated 2/16/23 and the Facility's Station 1 AM Shower Schedule were reviewed. LVN 1 stated Resident 83 was scheduled to have showers on Tuesday's, Thursday's and Saturdays. LVN 1 stated while reviewing the ADL Bathing/Shower document the documentation on 1/13/23-1/17/23, 1/19/23 and 1/23/23 indicated NA (not applicable). LVN 1 reviewed the nursing notes and other areas of Resident 83's electronic health record and stated she was not able to locate any notes indicating the resident had refused or why there were no showers given.
During an interview on 2/15/23, at 1:47 p.m., with the Director of Nursing (DON), the DON stated we try and encourage residents to take showers or baths three to four times a week and staff will adjust the schedules for the resident preferences. The DON stated she did not know what was meant by the NA on the ADL Bathing/Shower documentation and stated she would get back with an answer.
During an interview on 2/16/23, at 2:38 p.m., with two Certified Nursing Assistants (CNA), CNA 1 and CNA 2 both stated showers/baths are offered to residents three times a week.
During an interview on 2/17/23, at 10:35 a.m., with CNA 3, CNA 3 stated, NA for showers means it's not their shower day, not applicable. If shower is refused, hit (meaning to document/click) the refuse box. Every time the resident takes a shower, fill out a shower sheet with the body picture on it.
During an interview on 2/17/23, at 11:24 a.m., with The Director of Staff Development (DSD), the DSD stated she conducts the education for staff for bathing/showering and where it should be documented. The DSD stated this task comes up in the staff's PCC (Point click Care- electronic charting required for their shift) for their assigned showers. DSD stated staff are supposed to document if the activity was a bed bath or shower, chart and fill out a shower sheet even if the resident refused, and notify the nurse or charge nurse if the resident refused and obtain that nurses signature on the shower sheet. The DSD stated if the charge nurse is not available, the staff can bring it to her. The DSD stated she noticed the PCC is generating a shower for every shift, every day when the resident is admitted . The DSD stated since showers are showing up every day for some residents' staff have been clicking the NA if it is not their shower day.
During a concurrent interview and record review on 2/17/23, at 3 p.m., with the Director of Nursing (DON), Resident 83's shower sheets were reviewed. The DON stated residents are offered showers three times a week and the staff use a shower schedule based on what room the resident is in. The DON stated after reviewing the shower sheets for Resident 83's admission starting 12/15/22 and discharged [DATE], there were shower sheets missing for the following days 1/17/23, 1/21/23, 1/28/23 and 1/3/23. The DON stated it is the facility's practice if the resident refuses, the staff should still be filling out a shower sheet and indicate that the resident has refused along with telling the charge nurse that the resident refused and getting a signature on the shower sheet from the charge nurse. The DON stated she is not sure why this did not happen for Resident 83. The DON stated it is important that residents get their ADL (activities of daily living to include showers, oral care and more) care for proper hygiene.
Review of facility's Policy and Procedure (P&P) titled, Activities of Daily Living (ADLs), Supporting, dated 3/2018, indicated, Policy Statement Residents will provided with care, treatment and services as appropriate to maintain or improve their ability to carry out activities of daily living (ADLs). Residents who are unable to carry out activities of daily living independently will receive the services necessary to maintain good nutrition, grooming and personal and oral hygiene . 6. Interventions to improve or minimize a resident's functional abilities will be in accordance with the resident's assessed needs, preferences, stated goals and recognized standards of practice .
During a review of the facility's P&P titled, Resident Rights, dated 12/2016, indicated, Policy Statement Employees shall treat all residents with kindness, respect, and dignity . 1. Federal and state law guarantee certain basic rights to all residents of this facility. These rights include the resident's right to: a. a dignified existence; b. be treated with respect, kindness, and dignity; c.be free from abuse, neglect, misappropriation of property, and exploitation; . e. self-determination; . g. exercise his or her rights as a resident of the facility . h. be supported by the facility in exercising his or her rights .
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0692
(Tag F0692)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations, interviews, and record reviews, the facility failed to ensure a comprehensive and effective systematic ap...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations, interviews, and record reviews, the facility failed to ensure a comprehensive and effective systematic approach was implemented to monitor and maintain acceptable parameters of nutritional status for one of 76 sampled residents as evidenced when:
1. The facility failed to ensure Resident 74 with severe unplanned weight loss was identify in a timely manner and recommend nutritional interventions. This failure resulted in Resident 74 experienced severe unplanned weight loss 21 pound (lb.) 16.2 percent (%) within five months from 7/1/2022, until 12/3/2022.
2. The Registered Dietician failed to reevaluate Resident 74's comprehensive nutrition assessment per facility policy. This failure had the potential risk to place Resident 74 for impaired nutrition status or compromised nutritional status. (Cross reference F801).
Findings:
During a review of Resident 74's admission Record (document containing resident demographic information and medical diagnosis), dated 2/15/23, the admission record indicated Resident 74 was admitted to the facility on [DATE]. Resident's diagnoses included .Unspecified Dementia (the loss of ability to think, remember, learn and make decisions) .Muscle weakness (Lack of muscle strength) .Pure Hyperglycemia (high levels of cholesterol in the blood) .
A record review of Resident 74 was conducted.
During a weight record reviewed, Resident 74 had a 21 pound (lb.) 16.2 percent (%) weight loss in five months from July 1, 2022, until [DATE]. The five month weight loss percent was calculated using the 130 lbs. on 2/1/2022, and the 109 lbs. on 12/3/2022.
7/1/22- 130 lbs.
8/1/22- 120 lbs.
8/7/22-117 lbs.
8/15/22-118 lbs.
9/2/22-117.2 lbs.
10/2/22-114 lbs.
11/2/22-112 lbs.
12/3/22-109 lbs.
12/11/22-108 lbs.
12/18/22-108.2 lbs.
12/25/22-105.2 lbs.
12/28/22-105 lbs.
1/1/23-106 lbs.
1/8/23 107.6 lbs.
1/15/23-107 lbs.
1/22/23-107 lbs.
1/29/23-109.6 lbs.
2/2/23-110 lbs.
2/5/23-110.4 lbs.
During a review of Resident 74's Minimum Data Set (MDS) (a clinical assessment tool), Section K, dated 12/4/22, indicated, weigh loss of 5% or more in the last month-not on physician-prescribed weight-loss regimen.
During a review of Resident 74's Physician's orders dated, 2/15/23, the Physician's Orders indicated as the following .Date ordered 12/6/22: Fortified diet (diet with added extra nutrients to increase the calories and/or protein density to promote improvement in residents' nutrition status) Regular texture, Thin Liquids consistency, for weight loss . Dated ordered 1/5/23: House Nourishment (Nutrition drinks that has high calories and protein which use to promote improvement in residents' nutrition status) three times a day for weight loss with meals-give 4 oz . Dated ordered 1/5/23: Magic Cup (a special kind of ice cream has high calories which use for promoting improvement in residents' nutrition status) three times a day with meals-supplements . Dated ordered 5/31/22: Weekly weights x 4 weeks . Dated ordered 12/13/22: Megestrol Acetate Suspension 40 MG/ML Give 10 ml by mouth one time a day for Appetite Stimulant for 60 Days until end date 2/12/23 .
During a record review of Resident 74's Nutritional Risk Assessment (Admission), dated 6/10/22, the Nutritional Risk Assessment indicated, .F. Cueing at meals, .J.Significant weight changes: > or = 5 % within 30 days, . Comments: Severe 12 % weight loss from 150 pounds at the acute hospital. K. Food Intake: 26-74% of Meals .M. Resident information: . Most Recent Weight: 132.0 pound, Date: 6/02/2022 . Diet: Regular . S. Nutrition Goals/Monitoring and Evaluation: 1. Nutrition Goals/Monitoring and Evaluation: No significant nutrition issues .
During a review of Resident 74's Progress - Weight Change Note, dated 8/3/22, the Progress Note indicated, IDT (Interdisciplinary team): Certified Dietary Manager (CDM), Social Service Director (SSD), Registered Dietician (RD). Weight: 120 pounds 8/1/22. Comparison weight 7/1/22, 130 pounds, -7.7 %, -10 pounds per month. She consumed < 50 % on Regular diet and is refusing some meals. Son brings in food from outside sources that she enjoys. Eats with supervision.Encourage her to eat. Recommend dining room at lunch and dinner. Progress note signed by Registered Dietician (RD 2) .
During a review of Resident 74's IDT Weight Variance Assessment (WVA), dated 12/19/22, the WVA indicated, .Problem: 1. Weight -21.8 lbs. 2. Weight loss (%) -16.8, . 4. In (x) number of months: 5 months, .Current interventions: Megace, Fortified diet, Magic cup 2 times per day (BID), House Nourishment three times per day (TID), Diet: Fortified diet, Regular texture, This Liquids consistency, Average % intake: 32%, Nourishment: None, Appetite Stimulant: Megestrol Acetate Suspension 40 MG/ML, Previous Weight: 108lb. on 12/11/2022, current weight 108.2 lbs. on 12/18/2022, Review of Potential Casual Factors: Meal observation (Nursing/Dietary) Slow eater Root cause Analysis: Significant weight decrease may be related to 1. Decrease oral intake. 2. History of dementia, 3. Recent lumbar fracture. 4. Possible pain related to lumbar fracture.Intervention/Implementations: 1. Continue current diet. 2. Honor food preferences, 3. Encourage oral intake. 4. History of dementia. 5. Continue supplements. Add to task list. 6. Weekly weights. 7. Continue appetite stimulant. 8. CDM to re-obtain food preferences .
During a review of Resident 74's IDT Weight Variance Assessment (WVA), dated 12/27/22, the WVA indicated, .Problem: 1. Weight -24.8 lbs. 2. Weight loss (%) -19.1 . 4. In (x) number of months: 5 months, .Current interventions: Megace, Fortified diet, Magic cup BID, House Nourishment TID, Diet: Fortified diet, Regular texture, This Liquids consistency, Average % intake: 32%, Nourishment: Magic cup BID, House Nourishment TID, Appetite Stimulant: Megestrol Acetate Suspension 40 MG/ML, Previous Weight: 108.2 on 12/18/2022, current weight 105.2 lbs. on 12/25/2022, .Usual body weight: 132 lb. Review of Potential Casual Factors: Meal observation (Nursing/Dietary) Slow eater . Root cause Analysis: Significant weight decrease may be related to 1. Decrease oral intake. 2. History of dementia, 3. Recent lumbar fracture. 4. Possible pain related to lumbar fracture. Intervention/Implementations: 1. Continue current diet. 2. Honor food preferences, 3. Encourage oral intake. 4. Continue supplements. Add to task list. 5. Weekly weights. 6. Care conference for potential hospice .
During a review of Resident 74's IDT Weight Variance Assessment (WVA), dated 1/10/23, the WVA indicated, .Problem: 1. Weight -14 lbs. 2. Weight loss (%) -11.7 . 4. In (x) number of months: 6 months, .Current interventions: Megace, Fortified diet, Magic cup BID, House Nourishment TID, Diet: Fortified diet, Regular texture, This Liquids consistency, Average % intake: 39%, Nourishment: Magic cup BID, House Nourishment TID, Appetite Stimulant: Megestrol Acetate Suspension 40 MG/ML, Previous Weight: 106 on 1/1/2023, current weight 107.6 lbs. on 1/8/2023, .Usual body weight: 132 lb. B. Review of Potential Casual Factors: Meal observation (Nursing/Dietary) Slow eater .Root cause Analysis: Significant weight decrease may be related to 1. Decrease oral intake. 2. History of dementia, 3. Recent lumbar fracture. 4. Possible pain related to lumbar fracture. Intervention/Implementations: 1. Continue current diet. 2. Honor food preferences, 3. Encourage oral intake. 4. Continue supplements. Add to task list. 5. Weekly weights. 6. Refer to RNA dining when open .
During a review of Resident 74's IDT Weight Variance Assessment (WVA), dated 1/16/23, the WVA indicated, .Problem: 1. Weight -23 lbs. 2. Weight loss (%) -17.69 . 4. In (x) number of months: 6 months, .Current interventions: Megace, Fortified diet, Magic cup BID, House Nourishment TID, Diet: Fortified diet, Regular texture, This Liquids consistency, Average % intake: 37%, Nourishment: Magic cup BID, House Nourishment TID, Appetite Stimulant: Megestrol Acetate Suspension 40 MG/ML, Previous Weight: 107.6 on 1/8/2023, current weight 107 lbs. on 1/15/2023, .Usual body weight: 132 lb. B. Review of Potential Casual Factors: Meal observation (Nursing/Dietary) Slow eater Root cause Analysis: Significant weight decrease may be related to 1. Decrease oral intake. 2. History of dementia, 3. Recent lumbar fracture. 4. Possible pain related to lumbar fracture. Intervention/Implementations: 1. Continue current diet. 2. Honor food preferences, 3. Encourage oral intake. 4. Continue supplements. Add to task list. 5. Weekly weights. 6. Refer to RNA dining when open .
During a review of Resident 74's Interdisciplinary Team note, dated 1/19/23. The IDT note indicated, .IDT met 1/18/23 regarding weight loss -23 lbs. or -17.69 % in 6 months. Resident is on a fortified regular texture diet with thin liquid, 38% meal intake, history of dementia, possible pain due to Hx (history) of lumbar fracture, current/new interventions 1. Continue current diet. 2. Honor food preferences. 3. Encourage oral intake. 4. Continue supplements. Add to task list. 5. Weekly weights. 6. Refer to RNA dining when open and will notify MD for any changes .
During a review of Resident 74's IDT Weight Variance Assessment (WVA), dated 1/23/23, the WVA indicated, .Problem: 1. Weight -23 lbs. 2. Weight loss (%) -17.69 . 4. In (x) number of months: 6 months, .Current interventions: Megace, Fortified diet, Magic cup BID, House Nourishment TID, Diet: Fortified diet, Regular texture, This Liquids consistency, Average % intake: 38%, Nourishment: Magic cup BID, House Nourishment TID, Appetite Stimulant: Megestrol Acetate Suspension 40 MG/ML, Previous Weight: 107.6 on 1/15/2023, current weight 107 lbs. on 1/22/2023, .Usual body weight: 132 lb.Review of Potential Casual Factors: Meal observation (Nursing/Dietary) Slow eater Root cause Analysis: Significant weight decrease may be related to 1. Decrease oral intake. 2. History of dementia. Intervention/Implementations: 1. Continue current diet. 2. Honor food preferences, 3. Encourage oral intake. 4. Continue supplements. Add to task list. 5. Weekly weights. 6. Continue RNA dining. 7. Continue plan of care .
1. During a concurrent interview and record review, on 2/15/23, at 11:46 AM, with the Director of Nursing (DON) and the Registered Dietician (RD), Resident 74' Weight Change progress note, dated 8/3/22, Resident 74's IDT Weight Variance Assessment, dated 12/19/22, 12/27/22, 1/10/23, 1/16/23, 1/19/23 and 1/23/23 were reviewed. The RD stated criteria put Resident on weekly IDT weight variance was significant weight loss/gain 3 lbs. for 1 week, 5% in 1 month, 7.5% in 3 months, 10% in 6 months. The DON and the RD reviewed all IDT weight variance progress note and stated Resident 74 only have one IDT weight variance progress note on 8/3/22 from previous Registered Dietician. The DON and the RD acknowledged based the facility' Policy Nutritionally At Risk, the Nutritional at Risk Committee supposed monitor Resident 74 weekly for weight loss since 8/3/22. As evidence showed that the Nutritional at Risk Committee did not monitor and intervene in the care of Resident 74, Resident 74 experienced severe unplanned weight loss 21 pound (lb.) 16.2 percent (%) within five months from 12/1/2022, until 12/3/2022.
According to the American Academy of Family Physician journal, indicated Elderly patients with unintentional weight loss are at higher risk for infection, depression and death. (American Family Physician, February 15, 2002/Volume 65, Number 4).
According to the American Academy of Family Physician journal, indicated Involuntary weight loss can lead to muscle wasting, .depression and an increased rate of disease complications. Various studies demonstrated a strong correlation between weight loss and morbidity and mortality. One study showed that nursing home patients had a significantly higher mortality rate in the six months after losing 10 percent of their body weight, irrespective of diagnoses or cause of death. In another study, institutionalized elderly patients who lost 5 percent of their body weight in one month were found to be four times more likely to die within one year. (February 15, 2002/Volume 65, Number 4 www.aafp.org/afp American Family Physician).
During a review of the facility's policy and procedure (P&P) titled, Nutritionally At Risk (NAR) Committee, dated 12/30/14, the P&P indicated,The facility has a Nutritionally at Risk (NAR) Committee for the purpose of monitoring and intervening in the care of patients as it relates to weight loss and weight gains . Procedure: The committee will identify, prevent, and reduce the risk factors associated with nutritional disorders. Criteria for NAR monitoring: Significant weight loss/gain -3% in 1 week, 5% in 1 month, 7.5% in 3 months, 10% in 6 months .Consuming less than 50 % of meals and weight loss has been identified. Key Components and Procedures for NAR Monitoring 1.It is the responsibility of the entire team (dietician, Director of Nursing, QA (Quality Assurance) Nurse, Unit managers, ADON (Assistant Director of Nursing), Social Service (S.S), Nurse Assessment Coordinator (MDS), Dietary Manager and Administrator) to assure that all residents meeting the criteria for NAR monitoring are placed on the weekly weight list .
2. During a concurrent interview and record review, on 2/15/23, at 11:46 AM, with the Registered Dietician (RD). Resident 74 had history of several unplanned weight loss since July 1, 2022, there was no reevaluate comprehensive nutrition assessment done by the RD. The RD stated, it should be a more recent comprehensive nutritional assessment for Resident 74. I do plan to see her. She is on my list of comprehensive nutritional assessment .
During a review of the facility's policy and procedure (P&P) titled, Nutritional Assessment, dated 2017, the P&P indicated, Policy Statement: As part of the comprehensive assessment, a nutritional assessment, including current nutritional status and risk factors for impaired nutrition, shall be conducted for each resident.
Policy Interpretation and Implementation:
1. The dietitian, in conjunction with the nursing staff and healthcare practitioners, will conduct a nutritional assessment for each resident . as indicated by a change of condition that places the resident at risk for impaired nutrition.
2. As part of the comprehensive assessment, the nutritional assessment will be systematic, multidisciplinary process that includes gathering and interpreting data and using that data to help define meaningful interventions for the resident at risk for or with impaired nutrition.
3. The nutritional assessment will be conducted by the multidisciplinary team and shall identify at least the following components: . d.) Dietitian: (1) An estimate of calorie, protein, nutrient and fluid needs; (2) Whether the resident's current intake is adequate to meet his or her nutritional needs. (3) Special food formulations .
During a review of the facility's Job Description position titled, Registered Dietician, dated on 9/2017, the Job Description indicated, General Purpose: Complete nutritional .and significant change reviews on residents according to federal and state guidelines.Complete nutritional reviews monthly on high risk residents (significant weight loss, .). Essential Duties: .Assess nutritional needs .
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0757
(Tag F0757)
Could have caused harm · This affected 1 resident
Based on observation, interview, and record review, the facility failed to ensure residents were free of unnecessary drugs for two of five sampled residents (Resident 5 and Resident 41) when:
1. Facil...
Read full inspector narrative →
Based on observation, interview, and record review, the facility failed to ensure residents were free of unnecessary drugs for two of five sampled residents (Resident 5 and Resident 41) when:
1. Facility failed to remove lidocaine patch (used for relief of neuropathic nerve pain [occurs when a health condition damages the nerves that carry sensation to the brain]) to left knee within 12 hours as specified by manufacturer guidelines for Resident 5.
2. Facility failed to monitor, and order Thyroid Stimulating Hormone (TSH- a hormone produced by the pituitary gland [a gland in the brain]. It prompts the thyroid gland to make and release thyroid hormones into the blood) labs (a blood test which measures TSH) annually as clinically indicated for levothyroxine (used to treat thyroid hormone deficiency) for Resident 41.
Theses failures had the potential for Residents prescribed medications to be inadequately monitored and assessed for the need and effectiveness of the medications being received.
Findings:
1. During an observation of medication administration on 2/14/23, at 9:12 a.m., at Station 3 with Registered Nurse (RN) 1, RN 1 placed a lidocaine 4% patch to Resident 5's left knee. No prior patch in place that required removal was noted or observed.
During a concurrent interview and record review, on 2/14/23, at 2:15 p.m., with License
Vocational Nurse (LVN) 4, LVN 4 reviewed Point Click Care (PCC- Health care software that stores residents' health record electronically) and indicated Resident 5's PCC Electronic Medical Record (E-MAR) lidocaine patch 4% with start date of 5/3/22 stated, Apply to left knee topically one time a day for left knee pain and remove per schedule. Scheduled for application daily at 9 a.m. and removal at 8:59 a.m. LVN 4 stated according to the schedule, the patch would be left on the left knee for 24 hours prior to removal, followed by immediate application of a new lidocaine patch. Upon reviewing the manufacturer instruction provided by facility, LVN 4 stated the manufacturer guidelines indicated lidocaine patch should be on for 12 hours within a 24-hour period. LVN 4 acknowledged the facility was not following directions according to manufacturer guidelines.
LVN 4 stated if the lidocaine patch was left on more than what the manufacturer indicated, the possibility of skin irritation and interactions with other medications could possibly occur for Resident 5.
During a concurrent interview and record review, on 2/14/23, at 2:50 p.m., with the Director of Nursing (DON) and RN 1, the DON reviewed PCC and stated Resident 5's current order indicated lidocaine patch to be applied at 9 a.m. and removed right before administration at 8:59 a.m. RN 1 stated Resident 5's mother was very involved in care and when she stated her son was in pain so primary physician ordered lidocaine Patch to left knee.
During a review of Resident 5's E-MAR record dated 2/15/23, the E-MAR indicated .lidocaine order start date of 5/2/22 18:55, Lidocaine path 4% Apply to left knee topically one time a day for left knee pain and remove per schedule .
During a concurrent interview and record review, on 2/15/23, at 3:05 p.m. with the DON, the DON stated order for lidocaine patch has been clarified and changed to lidocaine patch to be applied at 9 a.m. and removed and 9 p.m. The DON acknowledged the nursing staff was not removing and applying Resident 5's lidocaine patch according to manufacturer specifications. The DON stated medication has been proven to work best when following manufacturer guidelines. The DON stated irritation would occur if patch was not used per manufacturer guidelines.
During an interview on 2/15/23, at 3:56 p.m. with the Contracted Registered Pharmacist (RPH), the RPH stated, lidocaine patch should be removed within 12 hours and that is the standard to which he would hold the facility. RPH stated usually lidocaine patches are ordered in two separate orders, one order for application time and another for removal time. RPH stated it is important to follow manufacture guidelines in order to prevent accumulation when patch remains on past the designated allotted time; removing patch as per guidelines prevents irritation.
During a review of the facility's P&P titled, Administering Medications revised 4/2019, the P&P indicated, .Medication are administered in accordance with prescriber orders .
2. During a concurrent interview and record review, on 2/14/23, at 2:45 p.m., with RN 1, RN 1 reviewed PCC indicated Resident 41 received 75 mcg [microgram] (a unit of measurement) every day at 6 a.m. with a start date of 12/23/22. RN 1 was unable to provide documentation of lab monitoring of levothyroxine for the year 2022. RN 1 stated the importance of TSH labs obtain proper medication dosage to ensure levothyroxine was helping Resident 41's condition.
During a review of Resident 41's clinical record, the DON was unable to provide documentation of TSH lab order or results for 2022. The DON acknowledged TSH labs should have been obtained for Resident 41.
During a concurrent interview and record review, on 2/15/23, at 3:05 p.m., with the DON, the DON stated Resident 41's TSH labs are important as they ensure medications are doing what they are supposed to in the proper dosage required. By not ensuring proper dosage is being provided, resident is at risk for weight fluctuations and behaviors.
During a review of Resident 41's admission Records, dated 2/15/23, the admission Records indicated Resident 41 diagnosis information history included .hypothyroidism (a common condition where the thyroid doesn't create and release enough thyroid hormone into your bloodstream) .
During a review of Resident 41's E-MAR record dated 2/15/23, the E-MAR indicated an order start date of 12/23/22 Levothyroxine Sodium Tablet 75 mcg, Give 1 tablet by mouth in the morning for Hypothyroidism. Administration of medication was noted on E-MAR with dates and initials of nurses providing the medication for the month of February.
During an interview on 2/15/23, at 3:55 p.m. with The RPH, the RPH stated TSH labs were generally conducted one a year unless a change of dosage then it is conducted within 6 weeks from that change. The RPH stated that the importance of TSH labs were to ensure normal ranges and desired effects of levothyroxine medication are being distributed.
During a review of DailyMed (https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=5be7ee95-a27e-409d-881f-927f42074033&type=pdf) a National library of Medicine that publishes up to date accurate drug labels to health care providers and general public . In adult patients with primary (thyroidal) hypothyroidism, serum TSH levels (using a sensitive assay) alone may be used to monitor therapy. The frequency of TSH monitoring during levothyroxine dose titration depends on the clinical situation but it is generally recommended at 6-8 week intervals until normalization.It is recommended that a physical examination and a serum TSH measurement be performed at least annually in patients .
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0836
(Tag F0836)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** BASED ON IDR REVIEW F756 WAS MOVED TO F836
Based on interview and record review, the facility's Pharmacy Consultant (PC) failed ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** BASED ON IDR REVIEW F756 WAS MOVED TO F836
Based on interview and record review, the facility's Pharmacy Consultant (PC) failed to follow standards of practice to identify irregularities and make recommendations for two of five sampled residents (Resident 5 and Resident 41) when:
1. Facility failed to remove lidocaine patch (used for relief of neuropathic nerve pain [occurs when the nerves that carries sensation to the brain is damage]) to left knee of Resident 5 within 12 hours as specified by manufacturer guidelines.
2. Facility failed to order Thyroid Stimulating Hormone (TSH- a hormone produced by the pituitary gland [a gland in the brain] which tells the thryroid how much hormone it [NAME] to make) labs - a blood test which measures the thyroid hormone level in the blood) annually as clinically indicated for Levothyroxine (used to treat thyroid hormone deficiency, including a severe form known as myxedema coma) for Resident 41.
These failures had the potential to result in the residents increased risk for adverse effects as follows but not limited to, skin irritation, burning, discomfort, redness or swelling for Resident 5 and not providing the proper dosage of medication for hypothyroidism (a condition where the thyroid doesn't create and release enough thyroid hormone into your bloodstream) for Resident 41.
Findings:
1. During an observation on 2/14/23, at 9:12 a.m., medication cart 3 on station 3 with Registered Nurse (RN 1), RN 1 was observed placing Lidocaine 4% patch to Resident 5's left knee. No prior patch in place that required removal was noted or observed.
During a concurrent interview and record review, on 2/14/23, at 2:50 p.m., with the Director of Nursing (DON), the DON reviewed Point Click Care (PCC- Health care software) and indicated Resident 5's order currently indicate Lidocaine patch to be applied at 9:00 a.m. and removed right before administration at 8:59 a.m.
During a concurrent interview and record review, on 2/14/23, at 2:15 p.m., with License Vocational Nurse (LVN4), LVN 4 reviewed Point Click Care and stated Resident 5's PCC Electronic Medical Record (E-MAR) Lidocaine patch 4% with start date of 5/03/22 states, apply to left knee topically one time a day for left knee pain and remove per schedule. Scheduled for application daily at 9:00 a.m. and removal at 8:59 a.m. LVN 4 stated according to that schedule the patch would be left on the left knee for 24 hours prior to removal and application of new Lidocaine Patch. Upon reviewing the manufacturer instruction provided by facility and reviewed by LVN 4, LVN 4 stated that manufacturer guidelines state patch should be on for 12 hours within a 24-hour period. LVN 4 stated, facility was not following directions according to manufacturer guidelines.
LVN 4 stated if the Lidocaine patch is left on more than what the manufacturer states, the possibility of skin irritation and interactions with other medications can possibly occur for Resident 5.
During a concurrent interview and record review, on 2/15/23, at 3:05 p.m., the DON stated order for Lidocaine patch has been rectified and order now indicated for Lidocaine patch to be applied at 9 a.m. and removed at 9 p.m. Previous orders were not according to manufacturer specifications per DON. The DON stated medication has been proven to work best when following manufacturer guidelines. The DON stated irritation would occur if patch was not used per manufacturer guidelines. The DON stated she will follow up with Resident 5's primary physician to obtain as needed orders in case patch were to fall off during care.
During a review of Resident 5's admission Records(AR- document with resident demographic information), dated 2/15/23, the AR indicated Resident 5's diagnosis information history included; .Polyneuropathy in diseases classified elsewhere (disease process that includes symptoms that range from weakness and a pins-and-needles sensation or loss of sensation) and .Quadriplegia (refers to paralysis from the neck down, including the trunk, legs and arms) .
During a review of Resident 5's Electronic Medication Administration(E-MAR), record dated 2/15/23, the E-MAR indicated Lidocaine order start date of 5/02/22 6:55 p.m., Lidocaine path 4% Apply to left knee topically one time a day for left knee pain and remove per schedule .
During an interview on 2/15/23, at 3:56 p.m. with the Contracted Registered Pharmacist (RPH), the RPH stated lidocaine patch should be removed within 12 hours and that is the standard he would hold the facility to do so. The RPH stated usually Lidocaine patches are ordered in two separate orders, one order for application time and another for removal time. The RPH states it is important to follow manufacture guidelines in order to prevent accumulation when patch remains on past the designated allotted time. Removing patch as per guidelines prevents irritation.
During a review of the facility's P&P titled, Pharmacy Services-Role of the Consultant Pharmacist revised April 2019, the P&P indicated, . The consultant pharmacist will provide specific activities related to medication regimen review including: . Appropriate communication of information to prescribers and facility leadership about potential or actual problems related to any aspect of medications and pharmacy services, including medication irregularities, and pertinent resident-specific documentation in the medical record, as indicated .
2.) During a concurrent interview and record review, on 2/14/23, at 2:45 p.m., with RN 1, RN 1 reviewed Point Click Care (PCC- Health care software) indicating Resident 41 receives 75 mcg [micrograms] (a unit of measurement) every day at 6:00 a.m. with a start date of 12/23/22 prescribed by Physician. No recent TSH labs were noted or observed in electronic medication administration records by RN 1. RN 1 stated the importance of TSH labs being ordered are to ensure adjustments are made for the medication in order to obtain proper dosage if not, the dosage is not helping her condition.
During a review of Resident 41's General Acute Hospital labs dated 10/01/21, TSH results indicated a range of 3.6 uIU[micro-international units per milliter]/ML [milliliter] (a unit of measurement) within the normal range of 0.4-5.5 iIU/ML. This lab was the most recent indication that the resident's TSH levels were checked while being on Levothyroxine. No TSH labs were collected for year 2022. Confirmed with DON.
During a concurrent interview and record review, on 2/15/23, at 3:05 p.m., with the DON, the DON stated Resident 41's TSH labs are important as they ensure medications are doing what they are supposed to in the proper dosage required. By not ensuring proper dosage is being provided, resident is at risk for weight fluctuations and behaviors.
During a review of Resident 41's AR dated 2/15/23, the AR indicated Resident 41 diagnosis information history included .Hypothyroidism (a common condition where the thyroid doesn't create and release enough thyroid hormone into your bloodstream) .
During a review of Resident 41's E-MAR record dated 2/15/23, the E-MAR indicated an order start date of 12/23/22 Levothyroxine Sodium Tablet 75 mcg, Give 1 tablet by mouth in the morning for Hypothyroidism. Administration of medication was noted on E-MAR with dates and initials of nurses providing the medication for the month of February.
During an interview on 2/15/23, at 3:55 p.m. with the RPH, the RPH stated, TSH labs are generally conducted one a year unless a change of dosage then it is conducted within 6 weeks from that change. The RPH stated the importance of TSH labs are ordered to ensure normal ranges and desired effects of Levothyroxine medication are being distributed.
During a review of the facility's P&P titled, Pharmacy Services-Role of the Consultant Pharmacist revised April 2019, the P&P indicated, . The consultant pharmacist will provide specific activities related to medication regimen review including: . Appropriate communication of information to prescribers and facility leadership about potential or actual problems related to any aspect of medications and pharmacy services, including medication irregularities, and pertinent resident-specific documentation in the medical record, as indicated .
During a review of Medline Plus (https://medlineplus.gov/lab-tests/tsh-thyroid-stimulating-hormone-test/), a National Library of Medicine used as a reliable public resource guideline for consumers, indicates . A TSH test is used to find out how well your thyroid is working . which allows physicians to treat appropriately with proper medication for those suffering from Hyper and Hypothyroidism.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0911
(Tag F0911)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation during the survey period of 2/13/23 through 2/17/23, the facility failed to ensure each bedroom accommodate...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation during the survey period of 2/13/23 through 2/17/23, the facility failed to ensure each bedroom accommodated no more than four residents in eight of 37 rooms (Rooms' 9, 11, 27, 29, 34, 36, and 38 and 39).
This failure had the potential to adversely effect care provided to residents.
Findings:
Throughout the survey period from 2/13/23 through 2/17/23, observations and interviews were conducted for the following rooms:
Rooms' 9, 11, 27, 29, 34, 36, 38 and 39. There was an open partition between room [ROOM NUMBER] and room [ROOM NUMBER] which would allow visitors, staff and residents to enter both rooms freely without accessing a door. There were four residents occupying room [ROOM NUMBER] and four residents in room [ROOM NUMBER], totaling eight residents with the shared open partition in the center wall of both rooms. The same configuration was observed for room [ROOM NUMBER] and room [ROOM NUMBER], room [ROOM NUMBER] and room [ROOM NUMBER], room [ROOM NUMBER] and room [ROOM NUMBER].
During survey observations and residents and staff interviews, there was reasonable amount of privacy provided, storage closet was adequate and storage space was available. Wheelchairs and toilet facilities were accessible to residents. There was sufficient space for residents and staff to provide resident care. Nursing care of the residents was not impacted.
Recommend waiver continue in effect.
--------------------------------------------------------------- Date
Health Facilities Evaluator Supervisor II
Signature
____________________________________
Facility Administrator Signature
Date
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0552
(Tag F0552)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. During a review of Resident 69's AR, dated 3/2021, the AR indicated, Resident 69 was admitted to the facility on [DATE]. Resi...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. During a review of Resident 69's AR, dated 3/2021, the AR indicated, Resident 69 was admitted to the facility on [DATE]. Resident 69's diagnoses included .MAJOR DEPRESSIVE DISORDER (mental condition characterized by persistent sadness, loss of pleasure or interest in life) . ANXIETY DISORDER (persistent and excessive worry that interferes with daily activities) . The AR indicated a Responsible Party (an individual that holds responsibility and oversees decision making for a resident) for the resident.
During a review of Resident 69's Minimum Data Set (MDS- a standardized assessment and care screening tool), dated 12/12/22, the MDS indicated, Resident 69's Brief Interview for Mental Status (BIMS- an evaluation of attention, orientation and memory recall. 0-7 severe cognitive impairment, 8-12 moderate cognitive impairment, 13-15 no cognitive impairment), scored 5 of 15 which indicated Resident 69 had severe cognitive impairment.
During a concurrent interview and record review, on 2/17/23, at 11:50 a.m., with DON, Resident 69's Informed Consent-Psychoactive Medication (ICPM), dated 12/19/22 was reviewed. The ICPM indicated Resident 69's Responsible Party agreed the use of mirtazapine (a medication used to treat depression [mood disorder characterized by feelings of sadness and loss of interest]) on 12/19/22. Resident 69's MAR was reviewed. The DON stated Resident 69 was administered mirtazapine once a day from 12/6/22 through 12/31/22. The DON stated the Informed Consent to administer mirtazapine to Resident 69 was not obtained and the doctor did not explain the risk and benefits to Resident 69's Responsible Party prior to medication administration and should have.
During a review of the facility's policy and procedure (P&P) titled, Resident Rights, dated 12/16, the P&P indicated, . 1. Federal and state laws guarantee certain basic rights to all residents of this facility. These rights include the resident's rights to: . be informed about his or her rights and responsibilities . be notified of his or her medical condition and of any changes in his or her condition. be informed of, and participate in, his or her care planning and treatment .
During a review of the facility's P&P titled, Informed Consent Policy, dated 4/17, the P&P indicated, the resident or responsible party will be provided informed consent when applicable . the physician will provide education to the resident or responsible party to include the risks, benefits, and alternatives of a given procedure or intervention .
Based on observation, interview and record review, the facility failed to ensure a physician Informed Consent (a process in which residents are given important information of the possible risk and benefits of the use of psychoactive medications) for the use of psychotropic medication (medication capable of affecting mind, emotions, and behavior) for two of five sampled residents (Resident 34, and Resident 69) was obtain when:
1. Resident 34 was administered lorazepam (medication used to treat anxiety [intense, excessive, and persistent worry and fear about everyday situations]) without an Informed Consent.
2. Resident 69 was administered mirtazapine (a medication used to treat depression [mood disorder characterized by feelings of sadness and loss of interest]) on 12/6/22 to 12/31/22 and Informed Consent was not obtained prior to medication administration.
These failures resulted for Resident 34 and Resident 69 to be administered with psychotropic medications and not fully informed of the risk and benefits and did not have the knowledge to make an informed decision which could place Resident 34 and Resident 69 at risk for negative side effects.
Findings:
1. During a concurrent observation and interview on 2/13/23, at 11:40 a.m., in room [ROOM NUMBER], Resident 34 was lying in bed watching TV. Resident 34 stated he was admitted in the facility on 12/2022 due to a fall and injured his back.
During a review of Resident 34's clinical record titled, admission Record (AR), (document with resident demographic information), dated 2/15/23, the AR indicated, Resident 34 was admitted on [DATE], with a diagnoses which included wedge compression fracture (break in the front of the vertebrae) of first and third lumbar ( lower back bones), anxiety and depression.
During a review of Resident 34's, Order Details dated, 12/31/22, the Order Details indicated, .[brand name] 1 MG [one milligram- unit of measurement] one tablet PRN [as needed] every 8 for Anxiety .
During a review of Resident 34's, Medication Administration Record (MAR- a document that shows the medications ordered and taken by an individual), dated 1/1/23-1/31/23, the MAR indicated, lorazepam medication was administered every day starting from 1/1/23 thru 1/11/23.
During a concurrent interview and record review on 2/15/23, at 1:49 p.m., with Licensed Vocational Nurse (LVN) 2, LVN 2 reviewed Resident 34's electronic clinical record order for lorazepam. LVN 2 stated the lorazepam was first ordered on 12/31/22, and the Informed Consent for the lorazepam was signed on 1/4/23. LVN 2 stated the lorazepam was administered to Resident 34 on 1/1/23, 1/2/23, 1/3/23 and 1/4/23 before the informed consent was signed. LVN 2 stated psychotropic medications should have an Informed Consent prior to administration. LVN 2 stated the licensed nurse who received the order for lorazepam should have obtained an Informed Consent and explained the risk and benefits to Resident 34 prior administration.
During a concurrent interview and record review on 2/17/23, at 9:50 a.m., with the Director of Nursing (DON), the DON reviewed Resident 34's electronic clinical record for the psychotropic medication Informed Consent form. DON stated Resident 34's Informed Consent for the lorazepam was signed on 1/4/23. DON stated Resident 34 was administered lorazepam medication on 1/1/23, 1/2/23, 1/3/23 and 1/4/23 without an Informed Consent signed. DON stated the lorazepam should have not been administered to Resident 34 without an Informed Consent.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Assessment Accuracy
(Tag F0641)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. During an observation on 2/13/23, at 10:55 a.m., Resident 17 was seen in her bed, head of bed elevated 30 degrees, slightly t...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. During an observation on 2/13/23, at 10:55 a.m., Resident 17 was seen in her bed, head of bed elevated 30 degrees, slightly turned to her left side, when we attempted to converse with Resident 17, she was talking to herself in Spanish and never indicated that she was being spoken to.
During a review of Resident 17's AR, dated 2/17/23, the AR indicated Resident 17 was an [AGE] year old female admitted on [DATE] with diagnoses that included Alzheimer's disease (generalized degeneration of the brain causing memory loss), major depressive disorder (mental condition characterized by persistent depressed mood and long-term loss of pleasure or interest in life), Anxiety disorder (intense excessive and persistent worry and fear about everyday situations), tremor (involuntary quivering movement), Osteoporosis (bones become brittle and fragile from loss of tissue).
During a review of Resident 17's MDS Section C Cognitive Patterns, dated 1/27/23, the MDS indicated in C0100 entered code '0', 0. No (resident is rarely/never understood) 'Skip to and complete C0700-C1000. Staff Assessment for Mental Status . C0700. Short-term Memory OK (coded) 1. Memory problem C0900. Long-term Memory OK (coded) 1. Memory problem . C1000. Cognitive Skills for Daily Decision Making (coded) 3. Severely impaired - never/rarely made decisions . Section M Skin Condition M0300. Current Number of Unhealed Pressure Ulcers/Injuries at End Stage (not coded) ., Sections M letters A-G are all uncoded indicating these areas were not filled in, Section N Medications . N0410. Medications Received Indicate the number of DAYS the resident received the following medications . during the last 7 days . Enter Days (coded) '0' F. Antibiotic .
During a review of Resident 17's, Change in Condition Evaluation (CCE), dated 1/10/23, the CCE indicated, 1. Signs & Symptoms Identified 1. The change in condition, symptoms or signs I am calling about is/are: (check marked) 25. Skin wound or ulcer 2. This starred on: 01/10/2023 3. What time of day did this start? (marked) 1. Morning . 3. Review Findings and Provider Notifications . 4. Summarize your observations, evaluation and recommendations: Hospice nurse here today to see resident, noted st. 2 pressure ulcer to palm of left hand. N.O. start on Metrodinazole (antibiotic) 250 mg [milligrams] tab topically as follows: cleanse area with n/s, pat dry, crush Metrodinazole tab apply to affected area, apply dry dressing and wrap with Kerlix (bandage rolls) x 7 days and monitor Q [every] shift for s/s [signs and symptoms] of infection .
During a review of Resident 17's MAR for 1/2023, the MAR indicated Resident 17 was on Metrodinazole . Apply to left palm topically in the evening for left palm wound infection until 01/24/2023 23:59 . Start Date- 01/18/2023 1900 .
During a concurrent interview and record review on 2/17/23, at 12:01 p.m., with the DON, Resident 17's Change of Condition Evaluation dated 1/10/23, MDS dated [DATE], and MAR for 1/2023 was reviewed. The DON stated the MDSC is in training and new to his position. The DON stated after reviewing the documents for Resident 17 the stage 2 pressure ulcer and the antibiotic Metrodinazole were not placed on the MDS dated [DATE] and the expectation was that if the stage 2 were still present and if the resident was still on the antibiotic within the 7 day look back period they should have been placed on the next MDS and this was not done.
During a review of facility's P&P titled, Resident Assessment, dated 3/22, the P&P indicated, .the interdisciplinary team uses the MDS form currently mandated by federal and State regulations to conduct the resident assessment .
Review of the Long Term Care Facility Resident Assessment Instrument (RAI) 3.0 User's Manual, Version 1.17.1, dated October 2019, indicated in Chapter 2 Assessments, An SCSA is appropriate when: there is a determination that a significant change (either improvement of decline in a resident's condition . resident's condition is not expected to return to baseline within two weeks . any decline in an ADL physical functioning area (at least 1) where a resident is newly coded as activity did not occur since last assessment . emergence of a new pressure ulcer at stage 2 or higher, a new unstageable pressure ulcer/injury, a new deep tissue injury or worsening in pressure ulcer status Must be completed . within 14 days after the determination that the criteria are met for a Significant Change in Status assessment.
1. During a review of Resident 9's face sheet titled admission Record, undated, the face sheet indicated, resident 9 was admitted to the facility on [DATE], with diagnoses which included fracture (break in bone) of shaft of right tibia (shin bone), rheumatoid arthritis (autoimmune disease causes inflammation in the body including joints), cerebral infarction (stroke- result of disrupted blood flow to the brain), wedge fracture of unspecified lumbar vertebrae (fractured spine), and personal history of malignant neoplasm of bronchus and lung (cancer in the tissues of the lung).
During a review of Resident 9's MDS assessment, dated 2/10/23, the MDS assessment indicated Resident 9's Brief Interview for Mental Status (BIMS-screening tool used in nursing facility to assess cognition) assessment score was 10 out of 15 (0-15 scale [0-6 severe cognitive deficit, 7-12 moderate cognitive deficit, 13-15 no cognitive deficit]) indicating Resident 9 has moderate cognitive deficit.
During a concurrent observation and interview on 2/15/23, at 11:42 a.m., Resident 9 was observed laying in bed with her eyes closed. Resident 9 had wound closure strips (strips of tape put across an incision or minor cut) on the back of the right hand. Resident 9 opened her eyes and stated she hit her hand on an object which caused a skin tear.
During a concurrent interview and record review on 2/15/23, at 4:25 p.m., with Licensed Vocational Nurse (LVN) 2 and LVN 3, Resident 9's physician orders dated 2/2023 was reviewed. Resident 9's physician orders indicated, .Enoxaparin Sodium Injection Solution Prefilled Syringe 40mg [milligrams]/0.4 ml [millilitters] (units of measurement) (Enoxaparin Sodium) Inject 40 mg subcutaneously one time a day for DVT PPX (deep vein thrombosis [a blood clot in the legs, pelvis] prophylaxis- [measured to diminish the risk of DVT]) for 2 weeks. LVN 2 stated Resident 9 received an anticoagulant injection daily. LVN 3 stated the anticoagulant increased Resident 9's risk for excessive bleeding in the body which could be dangerous, and the resident should be monitored for anticoagulant side effects.
During a concurrent interview and record review on 2/16/23, at 2:51 p.m., with the MDS, the MDS reviewed Resident 9's MDS admission assessment Section N dated 2/3/23, Section N indicated, .Injections . Record the number of days that injections of any type were received . last 7 days or since admission . [coded as 2] . Indicate the number of DAYS the resident received the following medications by pharmacological classification . during the last 7 days or since admission/entry or reentry if less than 7 days . Enter 0 if medication was not received by the resident during the last 7 days . Enter [number or] Days . Anticoagulant [coded as 0] . The MDS reviewed Section N and stated he had entered a 2 for injections since admission and 0 for anticoagulant. The MDS reviewed Resident 9's physician orders and medication administration record and stated Resident 9 had [brand name] anticoagulant injection twice since admission to the facility. The MDS stated the anticoagulant in Section N was inaccurate and should have been coded as 2.
During an interview on 2/17/23, at 9:50 a.m., with the DON, the DON stated her expectation was for the MDS assessment to be performed accurately and the MDS should match the assessment of the resident when it was reported to Centers for Medicare and Medcaid Services (a goverment agency which provides health coverage).
BASED ON THE IDR REVIEW, RESIDENTS' 43, 52, AND 7'S FINDINGS WERE DELETED, THEREFORE, LOWERING THE SCOPE/SEVERITY TO E.
Based on observation, interview, and record review, the facility failed to ensure the Minimum Data Set assessment (MDS-assessment of physical and psychological functions and needs) accurately reflected resident's health and functional status for two of nine sampled residents ( Resident 9 & Resident 17) when:
1. Resident 9's anticoagulant medication (medication used to prevent blood clots in the legs) was inaccurately coded on the MDS section N (medications).
2. Resident 17's new pressure ulcer and current antibiotic were not coded in the MDS.
These failures had the potential for Resident 9, and Resident 17's necessary care and services not met.
Findings:
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Comprehensive Care Plan
(Tag F0656)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, the facility failed to ensure a comprehensive, person-centered care plan (a p...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, the facility failed to ensure a comprehensive, person-centered care plan (a plan that provides direction for individualized care of the resident) was developed and implemented to meet the identified needs for 3 of 4 sampled residents (Resident 9, Resident 79 and Resident 40) when:
1. Resident 9 did not have a care plan addressing the use of anticoagulant medication.
This failure had the potential for Resident 9 to experience severe bruising and bleeding which could lead to serious medical condition and hospitalization.
2. The facility did not implement interventions and a plan of care to treat Resident 79's significant edema (when excess fluid collects in the body) to his bilateral (both right and left) upper extremities (arms).
This failure had the potential for Resident 79 to experience medical complications including fluid overload (too much fluid in the body), worsening heart failure (heart does not pump blood effectively) and shortness of breath which could lead to hospitalization.
3. Resident 40 was administered anticoagulant (blood thinner), and receiving oxygen via nasal cannula and did not have care plans for the use of anticoagulant medication and use of oxygen.
This failure had the potential for Resident 40 to experience severe bruising and bleeding which could lead to serious medical condition and respiratory needs not met.
Findings:
1. During a review of Resident 9's AdmissionRecord (AR), (a document that gives a patient's information at a quick glance, which includes brief medical history, preference, and contact information) undated, the face sheet indicated, Resident 9 was admitted to the facility on [DATE], with diagnoses which included fracture (break in bone) of shaft of right tibia (shin bone), rheumatoid arthritis (autoimmune disease causes inflammation in the body including joints), cerebral infarction (stroke- result of disrupted blood flow to the brain), wedge fracture of unspecified lumbar vertebrae (fractured spine), and personal history of malignant neoplasm of bronchus and lung (cancer in the tissues of the lung).
During a review of Resident 9's Minimum Data Set (MDS- a resident assessment tool used to identify resident cognitive, physical abilities and needs) assessment, dated 2/10/23, the MDS assessment indicated Resident 9's Brief Interview for Mental Status (BIMS-screening tool used to assess resident cognition status (0-15 scale [0-6 severe cognitive deficit, 7-12 moderate cognitive deficit, 13-15 no cognitive deficit]) assessment score was 10 out of 15 which indicated Resident 9 had moderate cognitive deficit.
During a concurrent observation and interview on 2/15/23, at 11:42 a.m., Resident 9 was observed lying in bed with her eyes closed. Resident 9 had a wound closure strips (a strip of tape put across an incision and minor cut) on the back of the right hand. Resident 9 opened her eyes and stated she hit her hand on an object which caused a skin tear.
During a concurrent interview and record review on 2/15/23, at 4:25 p.m., with Licensed Vocational Nurses (LVN) 2 , Resident 9's Physician Orders, dated 2/2023 was reviewed. Resident 9's physician orders indicated, .Enoxaparin Sodium Injection Solution [medication used to prevent blood clots in the legs] Prefilled Syringe 40mg[milligrams]/0.4 ml[milliliter] (unit of measurements) (Enoxaparin Sodium) Inject 40 mg subcutaneously one time a day for DVT PPX (deep vein thrombosis [a blood clot in the legs, pelvis] prophylaxis- [measured to diminish the risk of DVT]) for 2 weeks. LVN 2 stated Resident 9 was administered anticoagulant medication by way of injection daily.
During a concurrent interview and record review on 2/15/23, at 4:30 p.m., with LVN 3, Resident 9's electronic medical record (EMR-an electronic collection of medical information about a patient stored on a computer) undated was reviewed. LVN 3 stated she was unable to locate the care plan for the use of anticoagulation medication. LVN 3 stated the anticoagulant medication administered to Resident 9 was not care planned and placed Resident 9 at risk to go unmonitored for major bleeding complications from the use of anticoagulation medication.
During a concurrent interview and record review on 2/16/23, at 3:54 p.m., with the Director of Nurses (DON), the DON stated Resident 9's physician orders included an order for [brand name of anticoagulant] 40 mg one time daily from 2/4/23 to 2/18/23. The DON stated the [brand name of anticoagulant] should have been care planned on admission to the facility, and the care plan nursing interventions should have included to monitor Resident 9 for bruising, bleeding, discoloration, black tarry (dark sticky stools can indicate sign of internal bleeding) stools, severe headache, nausea and vomiting, diarrhea and report symptoms to the physician. The DON stated the anticoagulant was a high risk medication and the side effects should have been monitored closely to prevent serious medical complications from anticoagulant medication used.
During a review of the facility's Policy and Procedure (P&P) titled Anticoagulation-Clinical Protocol, dated November 2018, The P&P indicated, .Assessment and Recognition . 1. As part of the initial assessment, the physician and staff will identify individuals who are currently anticoagulated; for example those with the recent history of deep vein thrombosis DVT (blood clots in the deep veins which could loosen and travel to lungs), or heart valve replacement, atrial fibrillation (irregular rapid heart beat) or those who have had recent joint replacement surgery . a. Assess for any signs or symptoms related to adverse drug reactions due to medication alone or in combination with other medications . b. Assess for evidence of effects related to the subtherapeutic (lower than therapeutic) or greater than therapeutic drug level related to that particular drug . 2. In addition, the nurse shall assess and document/report the following . a. Current anticoagulation therapy, including drug and current dosage . b. Recent labs, including therapeutic drug monitoring . 5. The staff and physician will monitor for possible complications in individuals who are being anticoagulated, and will manage related problems . a. If an individual on anticoagulation therapy shows signs of excessive bruising, hematuria (blood in urine), hemoptysis (coughing up blood), or other evidence of bleeding, the nurse will discuss the situation with the physician before giving the next scheduled dose of anticoagulant .
2. During a review of Resident 79's AR, undated, the admission record indicated, Resident 79 was admitted to the facility on [DATE] with diagnoses which included muscle wasting and atrophy (loss of muscle mass and decreased strength), type 2 diabetes mellitus (impairment in the way your body uses sugar for fuel), acute kidney failure (kidneys are not able to remove waste and extra water from blood), hypertensive heart disease with heart failure (chronic high blood pressure which causes heart to not pump blood effectively), and cirrhosis of the liver (scarring in the liver).
During a review of Resident 79's MDS assessment, dated 2/7/23, the MDS assessment indicated Resident 79's BIMS assessment score was 10 out of 15 indicating Resident 9 has moderate cognitive deficit.
During a concurrent observation and interview on 2/13/23, at 11:04 a.m., Resident 79 was observed sitting in a wheelchair next to his bed. Resident 79 was Spanish speaking only and hard of hearing. Resident 79's right hand had significant edema. Resident 79 held up his hands and made fists, his right hand remained significantly swollen and the knuckles were not visible. Resident 79's left hand had moderate edema with his knuckles slightly visible. Resident 79 wore brown, elastic geri-sleeves (used to provide slight compression to aid in relieving the discomfort associated with swelling) on bilateral arms, Certified Nursing Assistant (CNA) 4 entered the room and adjusted the sleeves down over Resident 79's hands. CNA 4 stated the edema to Resident 79's hands had been present for a few days.
During a concurrent interview and record review on 2/15/23, at 4:16 p.m., with LVN 2, Resident 79's care plans were reviewed. LVN 2 stated she was unable to locate a care plan addressing Resident 79's upper extremity edema. LVN 2 stated the purpose of care plans were direct the nursing interventions for the resident's care.
During a concurrent interview and record review on 2/15/23, at 4:20 p.m., Resident 79's care plans were reviewed. LVN 3 stated she was the treatment nurse and Resident 79 had significant edema to his upper extremities. LVN 3 stated she located a care plan for heart failure but it did not address the upper extremity swelling and edema. LVN 3 stated she was unable to locate a care plan addressing the upper extremity edema. LVN 3 stated the licensed nursing staff should have assessed Resident 79's upper extremities and entered a care plan to direct the medical care of the resident.
During a concurrent interview and record review on 2/16/23, at 11:22 a.m., with LVN 2, Resident 79's physician orders (PO) dated February 2023 were reviewed. LVN 2 stated she was unable to locate an order to monitor Resident 79's upper extremities. LVN 2 stated edema could affect Resident 79's blood pressure and cause fluid overload. LVN 2 stated she was unable to locate a care plan regarding Resident 79's upper extremity edema and if it was not documented it was not done. LVN 2 stated care plans were important because another nurse should be able to review a care plan and have a full picture of what the resident needs were and how to meet them.
During an interview and record review on 2/16/23, at 3:16 p.m., with the DON, Resident 79's PO, care plans and nurse's notes were reviewed. The DON stated Resident 79 had chronic edema to his legs. The DON stated Resident 79 had a recent weight gain due to his edema and starts and stops [brand name of diuretic]. The DON looked surprised when asked if she had looked at Resident 79's arms and would not answer if she was aware of the upper extremity edema. The DON reviewed the PO dated February 2023 and stated Resident 79 had geri-sleeves ordered for his arms on 2/12/23. The DON reviewed the indication for the geri-sleeves and stated they were ordered due to his picking at the skin. The DON reviewed Resident 79's admission assessment and stated the admission assessment indicated left hand swelling, abrasions and bruises to arms. The DON reviewed Resident 79's care plans and stated she was unable to locate a care plan for the bilateral upper extremity edema. The DON stated the licensed nurses should have entered a care plan to address the upper extremity edema. The DON stated Resident 79's care plan needed to be updated to provide Resident 79 the best care.
During a review of the facility's Policy and Procedure (P&P) titled Care Plans, Comprehensive Person Centered, dated March 2022, the P&P indicated, .A comprehensive, person-centered care plan that includes measurable objectives and timetables to meet the residents physical, psychosocial and functional needs is developed and implemented for each resident . Policy interpretation and implementation . 3. The care plan interventions derived from a thorough analysis of the information gathered as part of the comprehensive assessment . 7. The comprehensive, person centered care plan . a. includes measurable objectives and time frames . b. describes the services that are furnished to attain or maintain the residence highest practicable physical, mental, and psychosocial well-being, including . (1) Services that would otherwise be provided for the above .(3) Which professional services are responsible for each element of care . c. Includes the resident stated goals upon admission and desired outcomes .e. Reflex currently recognize standards of practice for problem areas and conditions . 9. Care plan interventions are chosen only after data gathering, proper sequencing of events, careful consideration of the relationship between the residents problem areas and their causes, and relevant clinical decision making . 10. When possible, interventions address the underlying source(s) of the problem area(s), not just symptoms or triggers . 11. Assessments of residents are ongoing and care plans are revised as information about the residents and the residents conditions change .
3. During a concurrent observation and interview on 2/13/23, at 11:30 a.m., in Resident 40's room, Resident 40 was observed with oxygen via nasal cannula (plastic tubing device to deliver supplemental oxygen), family member (FM) 2 at bedside. Resident 40 was Spanish Speaking and FM 2 was interpreting. FM 2 stated Resident 40 had been in the facility for more than two months.
During a review od Resident 40's clinical record titled, admission Record, dated 2/15/23, indicated Resident 40 was admitted to the facility with diagnosis of atrial fibrillation ([AFIB]irregular, often rapid heart rate that commonly causes poor blood flow).
During a concurrent interview and record review on 2/15/23, at 11:45 a.m., with Licensed Vocational Nurse (LVN) 1, Resident 40's Order Summary Report dated 2/15/23, was reviewed. Order Summary Report undated, indicated, . Oxygen- at 2 Liters/Min via nasal cannula PRN (as needed) for SOB (shortness of breath). Goal to maintain 02 (oxygen) sats (saturation) greater than 90% (percent) as needed for SOB . Order Status Active . Order Date 02/11/2023 . [[NAME] name] Tablet 2.5 MG [milligram-unit of measure-used to prevent blood clots]. Give 1 tablet by mouth two times a day for AFIB . Order Status Active . Order Date 11/29/22 . LVN 1 reviewed Resident 40's care plans. LVN 1 stated, there was no care plan developed for the use of oxygen and [brand name]. LVN 1 stated care plans was developed to direct the care of the resident. LVN 1 stated the care plan should have been started as soon as the orders were received and the nurse who received the orders should have made the care plan.
During a concurrent interview and record review on 2/15/23, at 3:03 p.m., with LVN 5, LVN 5 stated Resident 40 used oxygen via nasal cannula and was started due to her difficulty of breathing. LVN 5 reviewed Resident 40's care plans and stated there was no care plan developed for the use of oxygen.
During an interview on 2/17/23, at 10 a.m., with the DON, the DON stated her expectation was for the licensed nurse to start the care plan right away as soon as the order was received. The DON stated she needed time to teach the licensed nurses to do care plans. The DON stated, . I need more time to clean up and help MDSC with the care planning .
During a review of the facility's policy and procedure (P&P) titled, Care Plans- Baseline, dated 2022, the P&P indicated, . The baseline care plan includes instructions needed to provide effective, person-centered care of the resident that meet professional standards of quality care and must include the minimum healthcare information necessary to properly care for the resident . A comprehensive care plan may be used in place of the baseline care plan providing the comprehensive care plan is developed within forty-eight (48) hours of the resident's admission and meets the requirements of a comprehensive care plan .
During a review of the facility's policy and procedure (P&P) titled, Care Plans, Comprehensive Person-Centered, dated 3/22, the P&P indicated, . The comprehensive, person-centered care plan is developed within seven (7) days of the completion of the required MDS assessment . The comprehensive, person-centered care plan: includes measurable objectives and timeframes; describes the services that are to be furnished to attain or maintain the resident; highest practicable physical, mental, and psychosocial well-being .
During a review of the facility's Policy and Procedure (P&P) titled Anticoagulation-Clinical Protocol, dated November 2018, The P&P indicated, .Assessment and Recognition . 1. As part of the initial assessment, the physician and staff will identify individuals who are currently anticoagulated; for example those with the recent history of deep vein thrombosis DVT (blood clots in the deep veins which could loosen and travel to lungs), or heart valve replacement, atrial fibrillation (irregular rapid heart beat) or those who have had recent joint replacement surgery . a. Assess for any signs or symptoms related to adverse drug reactions due to medication alone or in combination with other medications . b. Assess for evidence of effects related to the subtherapeutic (lower than therapeutic) or greater than therapeutic drug level related to that particular drug . 2. In addition, the nurse shall assess and document/report the following . a. Current anticoagulation therapy, including drug and current dosage . b. Recent labs, including therapeutic drug monitoring . 5. The staff and physician will monitor for possible complications in individuals who are being anticoagulated, and will manage related problems . a. If an individual on anticoagulation therapy shows signs of excessive bruising, hematuria (blood in urine), hemoptysis (coughing up blood), or other evidence of bleeding, the nurse will discuss the situation with the physician before giving the next scheduled dose of anticoagulant .
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Unnecessary Medications
(Tag F0759)
Could have caused harm · This affected multiple residents
Based on observation, interview and record review, the facility failed to ensure residents were free of medication errors in excess of five percent when the facility's medication error rate was 9.52 p...
Read full inspector narrative →
Based on observation, interview and record review, the facility failed to ensure residents were free of medication errors in excess of five percent when the facility's medication error rate was 9.52 percent. There were 42 opportunities for errors and 4 medication errors occurred with four of eight sampled residents (Resident 5, Resident 13, Resident 38 and Resident 41).
This failure resulted in medication errors for Resident 5, Resident 13, Resident 38 and Resident 41 which placed residents at risk of experiencing adverse side effects without adequate monitoring.
Findings:
1. During a medication pass observation on 2/14/23, at 7:58 a.m., with Registered Nurse (RN 1), RN 1 was observed preparing the following medications for Resident 13: Insulin Aspart (a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus [a disease that result in too much sugar I he blood] 14 units (a unit of measurement) and Insulin glargine (is a long acting insulin used in adults with type 2 diabetes and adults and children (6 years of age and older) with type 1 diabetes) 42 units (a unit of measurement). RN 1 administered insulin injections insulin Aspart 14 units to Lower right Abdomen and Insulin glargine 42 units to Upper Right Abdomen to Resident 13 who was in resting in bed.
During a concurrent interview and record review, on 2/14/23, at 1:54 p.m., with Registered Nurse (RN 1), RN indicated during the insulin injections for Resident 13, nursing staff have four options in the abdomen on where to inject, Left upper abdomen, Left lower abdomen, Right upper abdomen and Right lower abdomen. RN 1 stated nursing staff try to rotate sites but its whatever the resident prefers. RN 1 confirmed insulin injection to Left upper abdomen was utilized and documented for injection received on 2/14/23 at 7:58 a.m. as well as previous history on Point Click Care (PCC-Health Care software) indicated previous injection given and documented by RN 1 the day before on 2/13/23 at 7:47 a.m., was also given to Resident on Left upper abdomen. RN 1 stated it is important to rotate sites as resident may not be getting full absorption of insulin and blood sugars may not go down as indicated with use of insulin.
During a concurrent interview and record review, on 2/15/23, at 3:14 p.m., with Director of Nursing (DON), The DON stated the expectation for insulin administration is for nursing staff to rotate injection sites in order to make sure medication is absorbing correction, if not, resident may not be getting correct dosage. The DON will educate staff concerning rotation of sites and will provide body chart with designated locations to assist with rotation of sites.
During a review of Resident 13's admission Records, dated 2/15/23, the admission Records indicated Resident diagnosis information history included Type 2 Diabetes Mellitus (DM II) with other specified complications (is an impairment in the way the body regulates and uses sugar (glucose) as a fuel. This long-term (chronic) condition results in too much sugar circulating in the bloodstream. Eventually, high blood sugar levels can lead to disorders of the circulatory, nervous and immune systems) .
During a review of Resident 13's E-MAR (Electronic Medication Administration) record dated 2/15/23, the E-MAR stated Insulin glargine (, a drug used to control the amount of sugar in the blood of patients with diabetes) insulin pen-injector (a pre-filled pen that contains multiple doses of insulin) inject 42 units subcutaneously in the morning for DM II. Hold if FSBS (Fingerstick Blood sugar-one method of glucose (sugar) monitoring) is less than 70 or great than 400 .
During a review of Resident 13's E-MAR dated 2/15/23, the documentation for 2/13/23, at 7:47 a.m., indicated RN 1 documented subcutaneous injection of Lantus to Abdomen Left upper quadrant and on 2/14/23, at 7:58 a.m., documentation indicates RN injected Lantus subcutaneous to Resident 13's Left upper quadrant again, utilizing the same quadrant location as the day before. Blood sugar documented indicating a reading of 143 on 2/14/23.
During a review of clinical drug information from [name of facility's pharmacy] for Insulin glargine , manufacture guideline state . move site where you give the shot each time .
During a review of the facility's policy and procedure (P&P) titled, Administering Medications revised April 2019, the P&P indicated, .As required or indicated for a medication, the individual administering the medication records in the resident's medical record: . d. injection site (if applicable) .
During a review of Healthline (https://www.healthline.com/health/diabetes/lipohypertrophy#symptoms)a committed health guidance resource guideline, indicated .Lipohypertrophy (a lump of fatty tissue under your skin caused by repeated injections in the same place) can occur with repeated insulin injections in the same location which can cause fat and scar tissue to accumulate Areas with Lipohypertrophy can cause delays in absorption of medication administered to the affected area, like insulin, which can result in difficulties controlling blood sugar .
2. During a medication pass observation on 2/14/23, at 8:31 a.m., with RN 1, RN 1 was observed preparing the following medications for Resident 38: Insulin glargine 30 units and Insulin Aspart 18 units. RN 1 administered insulin injections to Resident 38's right lower abdomen. Resident 38 had a partially eaten breakfast tray which consisted of but not limited to a sesame seed sandwich and banana on the tray.
During a concurrent interview and record review, on 2/14/23, at 2:08 p.m., with RN 1, RN 1 indicated she administered Insulin Aspart 18 units of insulin injection to resident while Resident 38 had already started on his breakfast. Upon review of PCC, RN 1 stated orders indicate to provide insulin before meals. RN 1 states the importance to do so is to ensure accurate blood sugars are obtained prior to food consumption in order to provide correct dosage.
During a concurrent interview and record review, on 2/15/23, at 3:16 p.m., with the DON, the DON stated the expectation for insulin administration is for nursing staff normally provides insulin 15 minutes before meals. DON states since Resident 38 had already started eating, she would question if the blood sugar take was accurate prior to insulin administration. The DON states staff normally check blood sugar before the Residents meal.
During a review of Resident 38's admission Records, dated 2/15/23, the admission Records indicated Resident diagnosis information history included . Type 2 Diabetes Mellitus without complications (DM II) .
During a review of Resident 38's E-MAR dated 2/15/23, the E-MAR indicated Insulin Aspart 18 units insulin pen (device pre-filled with insulin) inject 18 units subcutaneously before meals and at bedtime for DM. Hold if FSBS is less than 80. Notify MD if FSBS is less than 70 or greater than 400. Blood sugar documented indicating a reading of 129 on 2/14/23 with injection of Insulin Aspart documented and administered on 2/14/23, at 7:03 a.m., to Left upper quadrant in abdomen by RN 1.
During a review of clinical drug information from [name of facility's pharmacy] for Insulin Aspart, manufacture guideline state . inject the dose within 5 to 10 minutes before a meal .
During a review of the facility's policy and procedure (P&P) titled, Administering Medications revised 4/2019, the P&P indicated, .Medications are administered in accordance with the prescriber orders, including any required time frame .
3. During a medication pass observation on 2/14/23, at 8:50 a.m., with RN 1, RN 1 was observed preparing the following medication for Resident 41 Fluticasone Nasal Spray (is used to relieve symptoms of nonallergic rhinitis such as sneezing and runny or stuffy nose). Bottle was new and unwrapped, RN 1 unwrapped bottle and while preparing medication, did not prime or shake spray prior to administration to resident. Resident self-administered medication while sitting up in wheelchair next to her bed. RN 1 did not provide instruction to Resident prior to self-administration.
During a concurrent interview and record review, on 2/14/23, at 2:15 p.m., with RN 1, RN confirmed, during medication observation pass, new bottle of Fluticasone was unwrapped but not primmed prior to administration of medication. RN 1 stated resident she did not provide instruction to resident as resident takes it everyday, so Resident knows. RN 1 stated it is important to prime bottle in order to get the adequate dosage.
During a concurrent interview and record review, on 2/15/23, at 3:14 p.m., with the DON , the DON stated the expectation for fluticasone is to prime bottle to ensure patient gets the accurate dosage and to follow manufacture specifications.
During a review of Resident 41's admission Records, dated 2/15/23, the admission Records indicated Resident 41's diagnosis information history included .Type 2 Diabetes mellitus with diabetic polyneuropathy(affects multiple peripheral sensory and motor nerves that branch out from the spinal cord into the arms, hands, legs and feet) . Type 2 Diabetes mellitus with Diabetic chronic kidney disease(affects the kidneys' ability to do their usual work of removing waste products and extra fluid from your body) .hypertensive heart disease without heart failure(a long-term condition that develops over many years in people who have high blood pressure) .
During a review of Resident 41's E-MAR record dated 2/15/23, the E-MAR indicated Fluticasone Propionate 1 spray in each nostril one time a day for Seasonal allergies one spray to each nostril once a day. RN 1 documented initials indicated administration on 2/14/23.
During a review of clinical drug information from Model Drug Inc for Fluticasone Nasal Spray, manufacture guideline state .some products may have different ways to prime the pump. Some pumps may also need to be primed if not used for different periods of time. Follow how and when to prime as you have been told . shake well before use .
During a review of the facility's policy and procedure (P&P) titled, Administering Medications revised 4/2019, the P&P indicated .Medications are administered in accordance with the prescriber orders .
4. During a medication pass observation on 2/14/23, at 9:12 a.m., with RN 1, RN 1 was observed preparing the following medication Phenytoin (used to control certain type of seizures, and to treat and prevent seizures that may begin during or after surgery to the brain or nervous system) 125 mg [milligrams]/5 ml [milliliters] (a unit of measurement) and poured out 5ml's in a plastic medicine cup (cups that are used for dispensing medications). RN 1 did not shake bottle of solution prior to pouring in medicine cup and administered medication via gastrostomy tube (also called a G-tube, is a tube inserted through the belly that brings nutrition directly to the stomach) to Resident 5.
During a concurrent interview and record review, on 2/14/23, at 2:50 p.m., with RN 1, RN confirmed, during medication observation pass, Phenytoin solution bottle was not shaken before pouring medication onto medicine cup prior to administration. RN 1 states the importance of shaking solution is to ensure Resident 5 is obtaining the correct prescribed dosage.
During a concurrent interview and record review, on 2/15/23, at 3:27 p.m., with the DON , the DON stated the expectation for Phenytoin solution, nursing staff are to follow manufacture guidelines and should be rocked prior to administration. If solution is not mixed properly, medication is not being given in the appropriate dosage.
During a review of Resident 5's admission Records, dated 2/15/23, the admission Records indicated Resident 5's diagnosis information history included; Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus (A disorder in which nerve cell activity in the brain is disturbed, causing seizures) .Unspecified convulsions (a sudden, violent, irregular movement of a limb or of the body, caused by involuntary contraction of muscles and associated especially with brain disorders such as epilepsy) .
During a review of Resident 5's E-MAR, record dated 2/15/23, the E-MAR indicated Phenytoin Suspension 125 mg/5 ml, Give 5 ml's via G-Tube three times a day for seizures. Documented administration noted on E-MAR by RN 1 on 2/14/23.
During a review of the facility's policy and procedure (P&P) titled, Administering Medications revised 4/2019, the P&P indicated .Medications are administered in accordance with the prescriber orders .
During a review of DailyMed, (https://medlineplus.gov/druginfo/meds/a682022.html) a National library of Medicine that publishes up to date accurate drug labels to health care providers and general public .Follow the directions on your prescription label . Shake the liquid well before each use to mix the medication evenly .
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0801
(Tag F0801)
Could have caused harm · This affected multiple residents
Based on interviews, and record review, the facility failed to ensure the Registered Dietician effectively monitored the food and nutrition services in accordance with the Registered Dietician job des...
Read full inspector narrative →
Based on interviews, and record review, the facility failed to ensure the Registered Dietician effectively monitored the food and nutrition services in accordance with the Registered Dietician job description when the Registered Dietician failed to monitor food services operations to ensure safe and sanitary food preparation and storage practices in the kitchen when:
1. Ice machine curtain had calcium build up.
2. The walk-in refrigerator food storage shelving contained a black fuzzy, brown, and white substance, the floor had decomposed food, the wall had black substance, and the door had brown and black grime.
3. The fan located above the dishwashing station was covered with brown debris and was blowing directly on the cleaned dish area
4. The can opener based in the kitchen was not kept in a sanitary condition and had black and brown grim build up.
5. The baseboard located under the ice machine had a hole, debris and trash.
6. The floor under the dish machine and dry storage room contained trash, debris, and food crumbs.
7. The reach in meat freezer, reach in refrigerator and reach in vegetable freezer gaskets were torn and contained black and brown grime.
8. The stainless-steel food preparation table had brown debris hanging and underneath stored 3 large white plastic containers.
9. The drying Dome (a piece of kitchen equipment used as a cover to keep food hot) rack was covered with brown debris.
10. The food shelving racks in the reach in refrigerator, dry storage room and walk-in refrigerator had chipped paint.
11. Expired and unlabeled food items were found in the Resident refrigerator.
These failures had the potential to place 73 out of 76 sampled residents at potential risk of exposure to foodborne illness (stomach illness acquired from ingesting contaminated food), compromised their nutrition status and further compromising resident's medical status. And also The Registered Dietician failed to reevaluate comprehensive nutrition assessment for Resident 74 had the potential risk to place Resident 74 for impaired nutrition status or compromised nutritional status. (Cross reference F692 and F812).
Findings:
During an interview on 02/13/23, at 10:16 AM, with the Registered Dietician (RD), the RD stated he had been working in this facility since December 2022, total 20 - 32 hours per week. And the RD also stated he did dietary sanitation audit quarterly.
During the initial kitchen tour on 02/13/23, at 10:30 AM, a concurrent observations and interviews were conducted of the overall kitchen sanitation and cleanliness with the RD and Food and Nutrition Service Director. The RD failed to monitor food services operations to ensure safe and sanitary food preparation and storage practices in the kitchen. (Cross reference F812)
During a concurrent interview and record review, on 02/15/23, at 11:46 AM, with the RD. Resident 74 had history of several unplanned weight loss since July 1, 2022, there was no reevaluate comprehensive nutrition assessment done by the RD. (Cross reference F692)
During an interview on 02/15/23, at 03:52 PM, with Administrator (ADM). With several deficient practices were identified during the survey in the areas of poor overall kitchen cleanliness, equipment maintenance, food safety and sanitation practices, ADM agreed the RD did not perform the job duties. ADM stated, I expect the RD perform kitchen inspection monthly instead quarterly, follow job description duties and identify any concerns regarding food and Nutrition services.
During a review of the facility's Job Description position titled, Registered Dietician, dated on 09/2017, the Job Description indicated, General Purpose: Complete nutritional initial .and significant change reviews on residents according to federal and state guidelines .Complete nutritional reviews monthly on high-risk residents (significant weight loss .) Essential Duties: .Assess nutritional needs, diet restrictions and current health plans to develop and implement dietary care plans . Monitor food services operations to ensure conformance to nutritional, safety, sanitation and quality standards, as well as state and federal regulations .
CONCERN
(F)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0761
(Tag F0761)
Could have caused harm · This affected most or all residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, the facility failed to ensure drugs and biologicals used in the facility were...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, the facility failed to ensure drugs and biologicals used in the facility were stored and labeled in accordance with current accepted professional standards of practice when:
1. Resident 34's Lorazepam (a medication used to treat anxiety disorders, trouble sleeping, severe agitation, active seizures including status epilepticus, alcohol withdrawal, and chemotherapy-induced nausea and vomiting) was discontinued on 2/11/13 and the medication was not separated from active medications and was stored in medication cart.
2. Resident 5's Lorazepam with directions that did not match current physician Lorazepam orders and the medication cards of Lorazepam did not have change of direction stickers.
These failures had the potential for Lorazepam to be administered past the discontinued date which could result in medication being distributed without physician orders and for Lorazepam to be administered incorrectly without updated directions as prescribed by physician.
3. A treatment cart in A wing station 1 hallway was left unlocked and unattended by Licensed Vocational Nurse (LVN) 3.
This failure resulted in the availability of medications to unauthorized residents, staff and visitors.
Findings:
1. During a concurrent observation and interview on 2/13/23, at 11:04 a.m., with LVN 4 at med cart 1, station 1, Resident 34's medication card was observed and indicated the following: Lorazepam 1 mg [milligram] (a unit of measurement) with directions indicating to provide 1 tablet by mouth T.I.D. (three times a day) PRN (as needed) with 63 total doses. The Lorazepam was observed inside the Narcotics locked storage bin inside the medication cart utilized for scheduled II (drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence) medications. LVN 4 stated when medications are discontinued from the locked storage bin, the DON is given the medication for destruction. LVN 4 indicated medication should not be stored in the medication cart after being discontinued.
During an interview on 2/13/23, at 11:19 a.m., LVN 4 stated the importance in removing medications after discontinuing was to assure medications are not accidentally given, administered, or popped from bubble packaging.
During an interview on 02/15/23, at 3:28 p.m., with the Director of Nursing (DON), the DON stated Resident 34's medications should have been removed right away and given to DON after discontinuing orders. The DON stated the potential harm if the medications are not given to the DON after discontinuing, there was a potential for it to be given if left with the other medications on the cart.
During a review of Resident 34's admission Records (AR- document with resident demographic information), dated 2/15/23, the AR indicated Resident 34 diagnosis information history included; Anxiety Disorder (A mental health disorder characterized by feelings of worry, anxiety, or fear that are strong enough to interfere with one's daily activities) .
During a review of Resident 34'sElectronic Medication Administration Record(E-MAR), dated 1/28/2023, the e-MAR indicated Lorazepam orders to be provided 1 tablet by mouth every 8 hours as needed for Anxiety for 14 days manifested by panicky feelings as evidence by feelings of head exploding, unable to become calm. Medication had a discontinued date of 02/11/23.
During a review of the facility's policy and procedure (IP&P) titled, Discontinued Medications revised 4/2007, the P&P indicated, .Staff shall destroy discontinued medications or shall return them to the dispensing pharmacy in accordance with facility policy . The Nurse receiving the order to discontinue a medication is responsible for recording the information and notifying the dispensing pharmacy of the discontinuation Discontinued medications must be destroyed or returned to the issuing pharmacy in accordance with the established policies .
2. During a concurrent observation and interview on 2/13/23, at 11:22 a.m., with Registered Nurse (RN) 1 at med cart #3, station 3, Resident 5's medication card was observed without a change of direction sticker on the medication card with #94 tablets with current orders indicating Lorazepam 0.5 mg take 1 tablet of 0.5 mg via G-tube (a tube inserted through the belly that brings nutrition directly to the stomach) everyday as needed. Can have every 5 minutes 2 tabs, no more than 4 tabs per day. RN 1 stated current medication orders indicated in E-MAR Lorazepam 0.5 mg provide 1 tab 0.5 mg via G-tube one time and day and every 8 hours as needed for seizures. RN 1 stated the current medication card should have a direction change sticker as orders have changed. RN 1 stated utilizing change of direction stickers are meant to provide staff the indication of a change of in orders to prevent medications errors which could affect the resident.
During an interview on 2/15/23, at 3:28 p.m., with the DON, the DON stated Resident 5's medications should have a change of direction sticker on the medication card as well as the narcotic sign off log.
During a review of Resident 5's AR dated 2/15/23, the AR indicated Resident 5's diagnosis information history included; Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus (A disorder in which nerve cell activity in the brain is disturbed, causing seizures) .Unspecified convulsions (a sudden, violent, irregular movement of a limb or of the body, caused by involuntary contraction of muscles and associated especially with brain disorders such as epilepsy).
During a review of Resident 5's E-MAR record dated 5/3/2022, the E-MAR indicated .Lorazepam 0.5 mg orders to be provided 1 tablet via G-Tube one time a day for seizures and Give 1 tablet via G-Tube every 8 hours as needed for Seizures. Start date indicated on 05/03/22 with end date being indefinite .
During a review of Resident 5's Physician Prescription, dated 7/12/22, the Physician Prescription indicated .Lorazepam 0.5 mg take 1 Tablet via G-tube every day as needed- can have every 5 minutes for 2 tabs not more than 4 tabs per day .
During a review of the facility's policy and procedure (P&P) titled, Appendix 23: CQI Process Example: Medication Labeling dated 2019, the P&P indicated, .was filled, a direction change sticker is affixed to container .
3. During an observation on 2/16/23, at 11:15 a.m., LVN 3 was observed preparing treatment for a resident in room [ROOM NUMBER]. LVN 3 left the treatment cart unlocked and unattended in the hallway and went inside room [ROOM NUMBER] and behind the privacy curtain. The unlocked treatment cart in the hallway was easily accessible to residents, staff and visitors.
During an interview on 2/16/23, at 11:30 a.m., with the DON, in the hallway next to the unlocked treatment cart, DON stated she locked the treatment cart because it was unlocked. DON stated treatment cart should always be locked whenever the licensed nurses turned their back so only the licensed nurses have access to the cart. DON stated other staff and residents could access the medications.
During an interview on 2/16/23, at 11:45 with LVN 3, LVN 3 stated she should have made sure the treatment cart was locked when she turned her back and went inside room [ROOM NUMBER]. LVN 3 stated there are medications in the treatment cart. LVN 3 stated staff and residents could have accessed the medications inside the treatment cart which could lead to self medication and or overuse of medication. LVN 3 stated the treatment cart should not have been left open and unattended.
During a review of the facility's policy and procedure (P&P) titled, Storage of Medications, dated 11/2020, the P&P indicated, . Drugs and biologicals used in the facility are stored in the locked compartments . Only persons authorized to prepare and administer medications have access to locked medications . Compartments (including, but not limited to, drawers, cabinets, rooms, refrigerators, carts, and boxes) containing drugs and biologicals are locked when not in use. Unlocked medication carts are not left unattended .
CONCERN
(F)
Potential for Harm - no one hurt, but risky conditions existed
Food Safety
(Tag F0812)
Could have caused harm · This affected most or all residents
Based on observation, interview, and record review, the facility failed to ensure food was stored, prepared, and served in accordance with the professional standards for food safety service and safety...
Read full inspector narrative →
Based on observation, interview, and record review, the facility failed to ensure food was stored, prepared, and served in accordance with the professional standards for food safety service and safety for 73 residents when:
1. The ice machine curtain had calcium build up.
2. The walk-in refrigerator food storage shelving contained a black fuzzy, brown, and white substance, the floor had decomposed food, the wall had black substance, and the door had brown and black grime.
3. The fan located above the dishwashing station was covered with brown debris, and was blowing directly on the cleaned dish area.
4. The can opener based in the kitchen was not kept in a sanitary condition and had black and brown grime build up.
5. The baseboard located under the ice machine had a hole, debris and trash.
6. The floor under the dish machine and dry storage room contained trash, debris, and food crumbs.
7. The reach in meat freezer, reach in refrigerator and reach in vegetable freezer gaskets were torn and contained black and brown grime.
8. The stainless-steel food preparation table had brown debris hanging and underneath stored 3 large white plastics containers.
9. The drying Dome (a piece of kitchen equipment used as a cover to keep food hot) rack was covered with brown debris.
10. The food shelving racks in the reach in refrigerator, dry storage room and walk-in refrigerator had chipped paint.
11. Expired and unlabeled food items were found in the Resident refrigerator.
These failures to ensure safety in food service, and sanitary condition resulted in the potential for residents to develop food-borne illnesses from cross contamination and growth of microorganism (living things that are too small to be seen with the naked eye, bacteria, viruses, and some molds) for 73 residents eating food prepared in the facility. (Cross reference 801)
Findings:
1. During a concurrent observation and interview, on 2/13/22, at 4:05 p.m., with the Registered Dietician (RD), the Food and Nutrition Service Director (FND) and the Maintenance Supervisor (MS), in the Kitchen. The ice machine curtain (a piece of plastic covered in front of ice maker where ice touched before traveling to the ice storage bin) had calcium build up. The FND stated the ice machine was the only ice machine in the building. The FND stated the dietary department used the ice made from the ice machine for food prep and served the ice to residents. The RD, the MS and the FND validated the calcium build on the ice machine curtain, and stated the ice machine curtain should not have a calcium build up. The RD stated the calcium build up on the ice machine had the potential for cross contamination and he expected the maintenance be held accountable to keep the ice machine clean and sanitary.
During a review of the facility's policy and procedures (P&P) titled, Sanitization, Revised 11/2021, the P&P indicated, Policy Statement: The food service area is maintained in a clean and sanitary manner. Policy Interpretation and Implementation: .3. All equipment, food contact surface .are cleaned .
2. During an observation on 2/13/23, at 11:32 a.m. there were 5 food storage shelving units in the walk-in refrigerator. The storage shelving units was brown and green colored. One of the green color shelving unit which had 3 food storage shelves had white substances spread all over underneath of the 2nd and 3rd food storage shelves. The two brown color shelving units which also had 3 food storage shelves had black fuzzy substances and brown substances spread all over underneath of the 2nd and 3rd shelves. Foods were stored on the top and under the food storage shelves which had black fuzzy, brown and white substances. Two tomatoes covered with gray fuzzy substances and white fuzzy substances found on the walk in refrigerator floor. There was black substances on the walk-in refrigerator wall and black and brown grime found on the walk-in refrigerator door.
During a concurrent observation and interview, on 2/13/23, at 3:01 p.m., with the RD, the FND, the Administrator (ADM), and the Infection Preventionist (IP), in the walk in refrigerator, the black fuzzy, brown and white substances on the food storage shelves were validated by the RD, the FND, the ADM, and the IP. The RD, the FND, the ADM, and the IP was not able to identify the black fuzzy, brown and white substances on the food storage shelves. The FND stated the walk-in refrigerator food storage shelves were cleaned once a week by the Prep [NAME] or the Dietary Aide. The FND stated when Prep [NAME] or the Dietary Aide cleaned the shelves, he/ she probably cleaned the top of the shelves not underneath. The FND stated the walk-in refrigerator food storage shelves should not have a black fuzzy, brown and white substances. The IP stated the black fuzzy, brown and white substances were probably dirt and 2 tomatoes on the floor were decomposed food.
During a concurrent observation and interview on 2/14/23, at 12:37 p.m., with Refrigerator Mechanical (Mech) vendor, in the walk-in refrigerator, the Mech stated the black substances on the walk-in refrigerator door and walls was dirt. The Mech stated the black grime on the door was dirt caused by hands from dietary staff opening and closing the door.
During an interview on 2/15/23, at 2:20 p.m., with the RD and in the presence of the FND, the RD stated the findings in the the walk-in refrigerator, which includes the black fuzzy, brown, and white substance found on food storage shelves, decomposed food on the floor, black and brown grime on the walls and door had the potential to attract pest, caused cross contamination, and was a food safety issue. The RD stated the dietary staff should keep the walk-in refrigerator clean free from food debris, dust, and build ups.
During a review of the facility's policy and procedures (P&P) titled, Sanitization, Revised 11/2021, the P&P indicated, Policy Statement: The food service area is maintained in a clean and sanitary manner. Policy Interpretation and Implementation: 1. All . kitchen areas .are kept clean, free from garbage and debris 2. All .shelves and equipment are kept clean .3. All equipment, food contact surfaces . are cleaned .
3. During a concurrent observation and interview, on 2/13/23, at 10:50 a.m., with the RD and the FND, at the dish washing station, the fan located above the dishwashing station covered with brown debris was blowing air directly towards the clean dishes. The RD stated the fan covered with brown debris blowing air directly to the clean dishes was not acceptable and had the potential to contaminate the clean dishes. The RD stated the expectation was to have the fan clean and maintain all the time.
During a review of the facility's policy and procedure (P&P) titled, Sanitization, Revised 11/2021, the P&P indicated, Policy Statement The food service area is maintained in a clean and sanitary manner. Policy Interpretation and Implementation 1. All kitchens, kitchen areas .are kept clean, free from .debris .3. All equipment, .are cleaned .
4. During a concurrent observation and interview, on 2/13/23, at 4:12 p.m., with the RD and the FND, in the kitchen, the base of the can opener was covered with black and brown grime and buildup. The RD stated the dietary staff should have clean the base of the can opener to prevent the potential risk of cross contamination.
During a review of the facility's policy and procedures (P&P) titled, Sanitization, Revised 11/2021, the P&P indicated, Policy Statement The food service area is maintained in a clean and sanitary manner. Policy Interpretation and Implementation .3. All equipment, food contact surfaces are cleaned .
5. During a concurrent observation and interview, on 2/13/23, at 11:08 a.m., with the RD, in the kitchen, underneath the ice machine had debris, trash and the baseboard of the wall had a quarter size hole. The RD validated the debris underneath the ice machine and the hole on the baseboard of the wall. The RD stated the hole to the baseboard had the potential to attract pests.
During an interview on 2/15/23, at 2:18 p.m., with the RD, the RD stated the hole to the baseboard underneath the ice machine was from a missing pipe. The RD stated the hole should have been filled, and cleanliness should have been maintain underneath the ice machine.
During a review of the facility's policy and procedures (P&P) titled, Sanitization, Revised 11/2021, the P&P indicated, Policy Statement: The food service area is maintained in a clean and sanitary manner. Policy Interpretation and Implementation: 1. All kitchens, kitchen areas .are kept clean, free from garbage and debris, and protected from rodents and insects.
During a review of the Federal Food and Drug Administration (FDA) 2022 Food Code indicated, Food Establishment shall be protected against the entry of insects and rodents by: Filling or closing holes and other gaps along floors, walls, and ceilings.
6. During a concurrent observation and interview, on 2/13/23, at 10:26 a.m., with the RD and the FND, at the dish washing station, the floor under the dish machine had trash, black grime, and a damage wooden shelf on the floor. The RD and the FND validated the floor under the dish washing machine had trash, black grime and damage wooden shelf on the floor. The RD stated the potential risk for not keeping the floor clean was the risk to attract pests.
During a concurrent observation and interview, on 2/13/23, at 3:32 p.m., with the FND, in the dry storage room, the floor underneath the storage shelves had food crumbs, black and brown debris, and trash. The FND validated the food crumbs, black and brown debris, and trash found on the floor underneath the storage shelves.
During an interview on 2/15/23, at 2:20 p.m., with the RD and the FND, the FND stated the floor underneath the appliances was not sanitary because dietary staff were unable to reach and clean underneath the appliances. The FND stated the dietary staff needed to do better in certain areas for sanitation. The RD stated he expected the dietary staff to keep the kitchen floor clean.
During a review of the facility's policy and procedure (P&P) titled, Sanitization, Revised 11/2021, the P&P indicated, Policy Statement: The food service area is maintained in a clean and sanitary manner. Policy Interpretation and Implementation: 1. All kitchens, kitchen areas .are kept clean, free from garbage and debris, and protected from rodents and insects .
7. During a concurrent observation and interview, on 2/13/23, at 10:52 a.m., with the RD and the FND, in the kitchen, the reach in meat freezer gaskets (rubber that is put between the door and the freezer to prevent cool air escaping) was torn, and the gaskets had black and brown grime.
During a concurrent observation and interview, on 2/13/23, at 11:19 a.m., with the RD and the FND, in the kitchen, the reach in refrigerator gaskets was torn and had brown and black grime on the gaskets.
During a concurrent observation and interview, on 2/13/23, at 11:25 a.m., with the RD and the FND, the reach in vegetable freezer had a torn gasket with brown and black grime. The RD and the FND confirmed the reach in meat freezer, reach in refrigerator and reach in vegetable freezer had torn gaskets with brown and black grime. The RD and FND stated the gaskets needed to be replaced. The RD stated the potential risk of a torn and dirty gaskets was food contamination for foods stored in the reach in meat freezer, reach in refrigerator and reach in vegetable freezer and it was a food safety issue.
During an interview on 2/15/23, at 2:25 p.m., with the RD, the RD stated he expected the gaskets of the reach in meat freezer, reach in refrigerator and reach in vegetable freezer needed to keep clean and damage free.
During a review of the facility's policy and procedure titled, Sanitization, Revised 11/2021, the P&P indicated, Policy Statement: The food service area is maintained in a clean and sanitary manner. Policy Interpretation and Implementation: .2. All .equipment are kept clean, maintained in good repair and are free from breaks, . open seams, .that may affect their use or proper cleaning .
8. During a concurrent observation and interview, on 2/13/23, at 4:13 p.m., with the RD and the FND, in the kitchen, Underneath the stainless-steel preparation table had an accumulation of brown debris hanging and there was 3 large white plastic storage containers keep under the stainless-steel preparation table. The RD and the FND validated the brown debris hanging underneath the stainless-steel preparation table. The RD stated the brown debris could potentially fall into the three large food storage containers.
During a review of the facility's policy and procedure titled, Sanitization, Revised 11/2021, the P&P indicated, Policy Statement: The food service area is maintained in a clean and sanitary manner. Policy Interpretation and Implementation 1. All kitchens, kitchen areas .are kept clean, free from .debris .3. All equipment, .are cleaned .
9. During a concurrent observation and interview, on 2/13/23, at 11:14 a.m., with the RD and the FND, in the kitchen, the Dome rack that stored clean domes was covered with brown debris. The FND stated, the brown debris is dust. The RD stated the potential risk for not keeping dome rack clean was cross contamination and he expected the dietary staff to keep the dome rack free from buildup and dust.
10. During a concurrent observation and interview, on 2/13/23, at 11:19 a.m., with the RD and the FND, in the kitchen, the reach in refrigerator had three gray shelves was worn with chipped paint and was validated by the RD and the FND.
During an observation on 2/13/23, at 11:32 AM, in the walk-in refrigerator, the green storage shelving units were worn, with chipped paint, a brown substance located on the posts of the shelves.
During a concurrent observation and interview, on 2/13/23, at 3:01 p.m., with the RD and the FND, the RD and the FND validated the green storage shelving units were worn, with chipped paint, had brown substance located on the posts of the shelves.
During a concurrent observation and interview, on 2/13/23, at 3:32 p.m., with the FND, in the dry storage room, three white storage shelving units had chipped paint and discoloration. The FND validated shelving unit had chipped paint and discoloration.
During an interview on 2/15/23, at 2:18 PM, with the RD and the FND, the RD and the FND stated the potential risk for chipped paint and discoloration on shelving units was potential for cross contamination. The RD expected all shelves keep in good condition, clean and sanitary on regular basis and free of dust, debris, and build up.
During a review of the facility's policy and procedure titled, Sanitization, Revised 11/2021, the P&P indicated, Policy Statement: The food service area is maintained in a clean and sanitary manner. Policy Interpretation and Implementation: .2. All .shelves . are kept clean, maintained in good repair and are free from .chipped areas that may affect their use or proper cleaning .
11. During a concurrent observation and interview, on 2/15/23, at 11:28 a.m., with the RD and the Director of Nursing (DON) in front of the resident refrigerator located at station 4, unlabeled and expired items were found in the resident refrigerator. Items found included, 3 unlabeled 10 ounces (oz- a unit of measurement) protein shake bottles with an expiration date of 1/25/23, 1 unlabeled 20 oz bottle of soda, one unlabeled 8 oz bottle of Chocolate drink with an expiration date of 1/16/23 and a box of 12-24-32 oz Squeeze Fruit and Veggiez packets with an expiration date of 11/03/22. The DON stated the resident refrigerator was only use to store residents' foods. The DON stated all food items stored in the resident refrigerator were supposed to be labeled with residents' name and expired foods should have been disposed to prevent the risk for resident to consumed expired food items.
During an interview on 2/15/23, at 2:20 p.m., with the RD, the RD stated it was the license nurse's responsibility to check for expired and unlabeled food items stored in the resident refrigerator. The RD stated stored expired and unlabeled food items in the resident refrigerator had the potential risk for a resident to consumed expired food products.
During a review of the facility's policy and procedure titled, Foods Brought in by Family/Visitors , Revised 3/9/2020, the P&P indicated, .7. The nursing staff is responsible for discarding perishable foods on or before the use by date .
During a review of the facility's policy and procedure titled, Bringing in Food for a Resident, Revised 11/12/2020, the P&P indicated, .Foods or beverages should be labeled with the resident's name and the date they were brought to the facility to monitor food safety .